Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Senseonics Holdings Inc (SENS)

Senseonics Holdings Inc (SENS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 287,239
  • Shares Outstanding, K 40,859
  • Annual Sales, $ 22,470 K
  • Annual Income, $ -78,620 K
  • EBIT $ -62 M
  • EBITDA $ -60 M
  • 60-Month Beta 0.92
  • Price/Sales 12.76
  • Price/Cash Flow N/A
  • Price/Book 3.66

Options Overview Details

View History
  • Implied Volatility 101.26% (-8.01%)
  • Historical Volatility 67.64%
  • IV Percentile 9%
  • IV Rank 24.85%
  • IV High 240.38% on 01/13/25
  • IV Low 55.26% on 08/19/25
  • Expected Move (DTE 8) 0.94 (13.35%)
  • Put/Call Vol Ratio 0.42
  • Today's Volume 47
  • Volume Avg (30-Day) 126
  • Put/Call OI Ratio 0.11
  • Today's Open Interest 92,251
  • Open Int (30-Day) 93,244
  • Expected Range 6.13 to 8.01

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.43
  • Number of Estimates 3
  • High Estimate -0.41
  • Low Estimate -0.45
  • Prior Year -0.40
  • Growth Rate Est. (year over year) -7.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.25 +34.29%
on 11/21/25
7.19 -1.95%
on 12/10/25
+0.54 (+8.29%)
since 11/11/25
3-Month
5.25 +34.29%
on 11/21/25
11.58 -39.10%
on 10/06/25
-2.06 (-22.58%)
since 09/11/25
52-Week
5.25 +34.29%
on 11/21/25
28.00 -74.82%
on 02/13/25
-0.16 (-2.22%)
since 12/11/24

Most Recent Stories

More News
Vistagen Appoints Nick Tressler as Chief Financial Officer

Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates...

SENS : 7.05 (+0.28%)
AZN : 90.29 (-1.33%)
VTGN : 3.95 (-12.80%)
Senseonics Holdings, Inc. to Participate in the Stifel 2025 Healthcare Conference

GERMANTOWN, Md., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable...

SENS : 7.05 (+0.28%)
Senseonics Announces Transfer to Nasdaq Stock Exchange

GERMANTOWN, Md., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable...

SENS : 7.05 (+0.28%)
Senseonics Holdings, Inc. Reports Third Quarter Financial Results

Generated Q3 revenue of $8.1 million, representing year-over-year growth of 90% Achieved a 160% increase in U.S. new patient starts over prior year Planning for the transition of CGM commercial...

SENS : 7.05 (+0.28%)
Lake Street Remains a Buy on Senseonics Holdings (SENS)

Lake Street analyst Ben Haynor maintained a Buy rating on Senseonics Holdings today and set a price target of $1.00. The company’s shares closed yesterday at $0.57.Elevate Your Investing Strategy: Take...

SENS : 7.05 (+0.28%)
Analysts Offer Insights on Healthcare Companies: Senseonics Holdings (SENS) and Arcus Biosciences (RCUS)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Senseonics Holdings (SENS – Research Report) and Arcus Biosciences (RCUS – Research Report) with bullish...

SENS : 7.05 (+0.28%)
RCUS : 25.14 (-1.02%)
Analysts Offer Insights on Healthcare Companies: Senseonics Holdings (SENS) and Arcutis Biotherapeutics (ARQT)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Senseonics Holdings (SENS – Research Report) and Arcutis Biotherapeutics (ARQT – Research Report) with...

SENS : 7.05 (+0.28%)
ARQT : 29.47 (-1.01%)
Senseonics Announces Preliminary Unaudited Revenue for Third Quarter 2025 and Provides Business Update

Preliminary unaudited revenue of $8.1 million for Q3 2025 Generated record quarterly new patient starts in Q3 2025 Established reverse stock split ratio of 1:20, anticipated to be effective October...

SENS : 7.05 (+0.28%)
Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365

CGM commercial operations to transition from Ascensia Diabetes Care to Senseonics Brian Hansen to be appointed Chief Commercial Officer Non-dilutive debt facility expanded up to $100 million...

SENS : 7.05 (+0.28%)
HTGC : 18.89 (-0.84%)
Senseonics Holdings, Inc. Reports Second Quarter Financial Results

Generated Q2 revenue of $6.6 million, representing year-over-year growth of 37% Achieved a 79% increase in U.S. new patient starts over prior year GERMANTOWN, Md., Aug. 06, 2025 (GLOBE NEWSWIRE)...

SENS : 7.05 (+0.28%)

Business Summary

Senseonics Holdings, Inc. is a medical technology company which focused on the design, development and commercialization of glucose monitoring systems. Senseonics Holdings, Inc. is based in Germantown, United States.

See More

Key Turning Points

3rd Resistance Point 7.47
2nd Resistance Point 7.33
1st Resistance Point 7.18
Last Price 7.05
1st Support Level 6.89
2nd Support Level 6.75
3rd Support Level 6.60

See More

52-Week High 28.00
Fibonacci 61.8% 19.31
Fibonacci 50% 16.63
Fibonacci 38.2% 13.94
Last Price 7.05
52-Week Low 5.25

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar